These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2461572)

  • 1. Metabolic inactivation of bleomycin analogs by bleomycin hydrolase.
    Sebti SM; Lazo JS
    Pharmacol Ther; 1988; 38(3):321-9. PubMed ID: 2461572
    [No Abstract]   [Full Text] [Related]  

  • 2. Murine strain differences in pulmonary bleomycin metabolism.
    Filderman AE; Lazo JS
    Biochem Pharmacol; 1991 Jun; 42(1):195-8. PubMed ID: 1712591
    [No Abstract]   [Full Text] [Related]  

  • 3. Bleomycin-resistant cells contain increased bleomycin-hydrolase activities.
    Akiyama S; Ikezaki K; Kuramochi H; Takahashi K; Kuwano M
    Biochem Biophys Res Commun; 1981 Jul; 101(1):55-60. PubMed ID: 6169344
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleomycin hydrolase activity and cytotoxicity in human tumors.
    Lazo JS; Boland CJ; Schwartz PE
    Cancer Res; 1982 Oct; 42(10):4026-31. PubMed ID: 6179595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity of bleomycin hydrolase.
    Sebti SM; DeLeon JC; Ma LT; Hecht SM; Lazo JS
    Biochem Pharmacol; 1989 Jan; 38(1):141-7. PubMed ID: 2462878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
    Lazo JS; Humphreys CJ
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
    Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
    Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of bleomycin hydrolase with a monoclonal antibody and its characterization.
    Nishimura C; Tanaka N; Suzuki H; Tanaka N
    Biochemistry; 1987 Mar; 26(6):1574-8. PubMed ID: 3109467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family.
    Sebti SM; Mignano JE; Jani JP; Srimatkandada S; Lazo JS
    Biochemistry; 1989 Aug; 28(16):6544-8. PubMed ID: 2477059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin hydrolase is a unique thiol aminopeptidase.
    Nishimura C; Suzuki H; Tanaka N; Yamaguchi H
    Biochem Biophys Res Commun; 1989 Sep; 163(2):788-96. PubMed ID: 2506856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular degradation of bleomycin hydrolase in two Chinese hamster cell lines in relation to their peplomycin susceptibility.
    Nishimura C; Suzuki H; Tanaka N; Yamaguchi H
    Biochim Biophys Acta; 1989 Jun; 1012(1):29-35. PubMed ID: 2471552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intracellular bleomycin hydrolase activity by E-64 leads to the potentiation of the cytotoxicity of peplomycin against Chinese hamster lung cells.
    Nishimura C; Nishimura T; Tanaka N; Yamaguchi H; Suzuki H
    Jpn J Cancer Res; 1989 Jan; 80(1):65-8. PubMed ID: 2468632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors.
    Nishimura C; Nishimura T; Tanaka N; Suzuki H
    J Antibiot (Tokyo); 1987 Dec; 40(12):1794-5. PubMed ID: 2448282
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice.
    Filderman AE; Genovese LA; Lazo JS
    Biochem Pharmacol; 1988 Mar; 37(6):1111-6. PubMed ID: 2451525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further characterization of bleomycin-resistant HeLa cells and analysis of resistance mechanism.
    Urade M; Sugi M; Matsuya T
    Jpn J Cancer Res; 1988 Apr; 79(4):491-500. PubMed ID: 2454906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nucleic acid binding activity of bleomycin hydrolase is involved in bleomycin detoxification.
    Zheng W; Johnston SA
    Mol Cell Biol; 1998 Jun; 18(6):3580-5. PubMed ID: 9584198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin hydrolase activity in pulmonary cells.
    Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity.
    Urade M; Ogura T; Mima T; Matsuya T
    Cancer; 1992 May; 69(10):2589-97. PubMed ID: 1373668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversed-phase paired-ion high-performance liquid chromatographic method for the separation and quantification of multiple bleomycin congeners.
    Klett RP; Chovan JP; Danse IH
    J Chromatogr; 1984 Oct; 310(2):361-71. PubMed ID: 6210296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells.
    Pei Z; Calmels TP; Creutz CE; Sebti SM
    Mol Pharmacol; 1995 Oct; 48(4):676-81. PubMed ID: 7476893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.